Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults

Voriconazole and anidulafungin in combination are being investigated for use for the treatment of pulmonary aspergillosis. We determined the pulmonary disposition of these agents. Twenty healthy participants received intravenous voriconazole (at 6 mg/kg of body weight every 12 h [q12h] on day 1 and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crandon, Jared L., Banevicius, Mary Anne, Fang, Annie F., Crownover, Penelope H., Knauft, R. Fredrick, Pope, J. Samuel, Russomanno, John H., Shore, Eric, Nicolau, David P., Kuti, Joseph L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786330/
https://ncbi.nlm.nih.gov/pubmed/19770284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01042-09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados